Phibro Animal Health CorpNASDAQ:PAHC
- LAST PRICE23.7400
- TODAY'S CHANGE (%)-0.0200 (-0.0842%)
- Bid / Lots23.6000/ 10
- Ask / Lots25.1000/ 1
- Open / Previous Close23.8800 / 23.7600
- Day Range
- 52 Week Range
- Volume132,856
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PAHC |
|---|---|---|
| 09:32 ET | 840 | 23.845 |
| 09:44 ET | 1128 | 23.965 |
| 09:46 ET | 1277 | 24.02 |
| 09:48 ET | 200 | 24.04 |
| 09:53 ET | 105 | 23.975 |
| 09:55 ET | 100 | 24.18 |
| 09:57 ET | 730 | 24.22 |
| 10:00 ET | 300 | 24.16 |
| 10:02 ET | 1164 | 24.2 |
| 10:04 ET | 100 | 24.34 |
| 10:08 ET | 100 | 24.285 |
| 10:09 ET | 100 | 24.285 |
| 10:11 ET | 2640 | 24.14 |
| 10:20 ET | 709 | 24.04 |
| 10:22 ET | 100 | 24.03 |
| 10:24 ET | 100 | 23.94 |
| 10:27 ET | 700 | 23.925 |
| 10:31 ET | 300 | 23.755 |
| 10:33 ET | 1100 | 23.91 |
| 10:36 ET | 149 | 23.875 |
| 10:42 ET | 100 | 23.84 |
| 10:51 ET | 600 | 23.83 |
| 10:54 ET | 300 | 23.855 |
| 10:58 ET | 500 | 23.885 |
| 11:00 ET | 100 | 23.9 |
| 11:02 ET | 600 | 24 |
| 11:05 ET | 200 | 23.96 |
| 11:09 ET | 400 | 23.96 |
| 11:14 ET | 100 | 23.9 |
| 11:16 ET | 1404 | 23.96 |
| 11:18 ET | 100 | 24.02 |
| 11:21 ET | 200 | 23.97 |
| 11:25 ET | 3396 | 24.03 |
| 11:27 ET | 600 | 23.96 |
| 11:30 ET | 200 | 24.02 |
| 11:32 ET | 800 | 24 |
| 11:43 ET | 200 | 24.015 |
| 11:52 ET | 200 | 24.01 |
| 11:56 ET | 100 | 23.96 |
| 12:01 ET | 354 | 24.05 |
| 12:03 ET | 300 | 24.015 |
| 12:08 ET | 100 | 24.015 |
| 12:14 ET | 600 | 24.09 |
| 12:15 ET | 100 | 24.1 |
| 12:17 ET | 100 | 24.1 |
| 12:21 ET | 200 | 24.09 |
| 12:30 ET | 100 | 24.11 |
| 12:32 ET | 980 | 24.09 |
| 12:35 ET | 100 | 24.07 |
| 12:39 ET | 100 | 24.07 |
| 12:44 ET | 300 | 24.1 |
| 12:46 ET | 100 | 24.095 |
| 12:50 ET | 200 | 24.095 |
| 12:53 ET | 100 | 24.12 |
| 12:57 ET | 512 | 24.07 |
| 01:02 ET | 200 | 24.11 |
| 01:15 ET | 100 | 24.14 |
| 01:18 ET | 2107 | 24.115 |
| 01:20 ET | 527 | 24.03 |
| 01:27 ET | 285 | 23.93 |
| 01:29 ET | 300 | 23.98 |
| 01:33 ET | 700 | 23.925 |
| 01:36 ET | 100 | 23.935 |
| 01:38 ET | 100 | 23.9 |
| 01:42 ET | 200 | 23.9 |
| 01:47 ET | 150 | 23.9 |
| 01:51 ET | 400 | 23.935 |
| 01:54 ET | 831 | 23.935 |
| 01:58 ET | 1248 | 23.9392 |
| 02:00 ET | 800 | 23.96 |
| 02:05 ET | 400 | 23.96 |
| 02:07 ET | 100 | 24.01 |
| 02:14 ET | 380 | 23.97 |
| 02:18 ET | 329 | 23.9 |
| 02:21 ET | 649 | 23.89 |
| 02:23 ET | 531 | 23.9 |
| 02:30 ET | 100 | 23.87 |
| 02:32 ET | 1900 | 23.96 |
| 02:41 ET | 100 | 23.99 |
| 02:45 ET | 200 | 24.0099 |
| 02:48 ET | 900 | 24.02 |
| 02:50 ET | 594 | 24.0605 |
| 02:52 ET | 100 | 24.065 |
| 02:54 ET | 500 | 24.065 |
| 02:56 ET | 1000 | 24.06 |
| 02:57 ET | 100 | 24.04 |
| 02:59 ET | 200 | 24.01 |
| 03:03 ET | 300 | 23.925 |
| 03:06 ET | 200 | 23.89 |
| 03:08 ET | 600 | 23.88 |
| 03:10 ET | 477 | 23.85 |
| 03:15 ET | 100 | 23.82 |
| 03:19 ET | 550 | 23.82 |
| 03:24 ET | 200 | 23.82 |
| 03:26 ET | 100 | 23.82 |
| 03:28 ET | 200 | 23.82 |
| 03:30 ET | 400 | 23.83 |
| 03:32 ET | 1509 | 23.78 |
| 03:33 ET | 800 | 23.825 |
| 03:37 ET | 100 | 23.8 |
| 03:39 ET | 195 | 23.83 |
| 03:42 ET | 300 | 23.81 |
| 03:44 ET | 1165 | 23.8207 |
| 03:46 ET | 2642 | 23.73 |
| 03:50 ET | 200 | 23.71 |
| 03:51 ET | 400 | 23.71 |
| 03:53 ET | 1508 | 23.765 |
| 03:55 ET | 1205 | 23.78 |
| 03:57 ET | 1000 | 23.805 |
| 04:00 ET | 28171 | 23.74 |
Nov 12, 2024
DJ Phibro Animal Health Is Maintained at Underweight by Barclays, from 10:15AM ET on Tuesday Nov 12, 2024 by Dow Jones
10:15AM ET on Tuesday Nov 12, 2024 by Dow Jones
Nov 6, 2024
Phibro Animal Health Corporation Reports First Quarter Results, Updates Financial Guidance, from 4:35PM ET on Wednesday Nov 06, 2024 by Dow Jones
4:35PM ET on Wednesday Nov 06, 2024 by Dow JonesPress Release: Phibro Animal Health Corporation Reports First Quarter Results, Updates Financial Guidance, from 4:35PM ET on Wednesday Nov 06, 2024 by Dow Jones
4:35PM ET on Wednesday Nov 06, 2024 by Dow Jones
Nov 5, 2024
Press Release: Phibro Animal Health Corporation Declares Quarterly Dividend, from 4:10PM ET on Tuesday Nov 05, 2024 by Dow Jones
4:10PM ET on Tuesday Nov 05, 2024 by Dow JonesPhibro Animal Health Corporation Declares Quarterly Dividend, from 4:10PM ET on Tuesday Nov 05, 2024 by Dow Jones
4:10PM ET on Tuesday Nov 05, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Phibro Animal Health Corp | 962.4M | 55.3x | -46.35% |
Supernus Pharmaceuticals Inc | 2.0B | 33.9x | -59.02% |
Eagle Pharmaceuticals Inc | 11.7M | 1.0x | -4.75% |
Elite Pharmaceuticals Inc | 659.9M | -106.0x | --- |
Shengtai Pharmaceutical Inc | 10.0 | 0.0x | --- |
Medicine Man Technologies Inc | 6.2M | --- | --- |
Company Information
Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
Contact Information
- Headquarters
- 300 Frank W. Burr Blvd. Suite 21, 65 Challenger RoadTEANECK, NJ, United States 07666
- Phone
- 201-329-7300
- Fax
- 302-655-5049
Executives
- Chairman of the Board, President, Chief Executive Officer
- Jack Bendheim
- Chief Financial Officer
- Glenn David
- President, North America Region
- Rob Aukerman
- Chief Operating Officer
- Larry Miller
- Executive Vice President - Corporate Strategy, Director
- Daniel Bendheim
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $962.4M |
|---|---|
Revenue (TTM) | $1.0B |
Shares Outstanding | 40.5M |
Dividend Yield | 2.02% |
Annual Dividend Rate | 0.4800 USD |
Ex-Dividend Date | 11-27-24 |
Pay Date | 12-18-24 |
Beta | 0.51 |
EPS | $0.43 |
Book Value | $6.34 |
P/E Ratio | 55.3x |
Price/Sales (TTM) | 0.9 |
Price/Cash Flow (TTM) | 17.9x |
Operating Margin | 6.85% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
